Company
Capnia
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
2
510(k), De Novo and PMA
Device trials
0
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$94.3M
10 Form D offerings, 2010 to 2023
Equity
$84.1M
Stock sold for cash
Debt and convertible notes
$10.2M
$10.2M of it convertible
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $60.0M raised of $60.0M sought, first sale Oct 2, 2023, 14 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Oct 2, 2023 | Equity | $60.0M | $60.0M | 14 | Rule 506(b)Commissions $3.6M | Form D ↗Oct 4, 2023 |
| Dec 15, 2017 | Equity | $15.0M | $15.0M | 16 | Rule 506(b)Commissions $1.1M | Form D ↗Dec 22, 2017 |
| Jan 27, 2017 | Equity Issued in a merger or acquisition; not counted as money raised | $602K | $17.0M | 1 | Rule 506(b) | Form D ↗Feb 8, 2017 |
7 more funding rounds with a free account
Company details
From the company's latest Form D.
- Legal name
- SOLENO THERAPEUTICS INC
- Headquarters
- Redwood City, California
- Incorporated
- Delaware over five years before filing
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Biotechnology
- SEC filer
- CIK 1484565 ↗
Executives, directors and promoters
As listed on the latest Form D.
8 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Capnia.
Latest FDA decisions
- CoSense ETCO Monitor510(k)
K253119 · Decided May 29, 2026 · 247 days after receipt
Device type: Analyzer, Gas, Carbon-Monoxide, Gaseous-Phase (CCJ) · Anesthesiology & Respiratory
- CoSense ETCO Monitor510(k)
K151107 · Decided Jul 22, 2015 · 86 days after receipt
Device type: Analyzer, Gas, Carbon-Monoxide, Gaseous-Phase (CCJ) · Anesthesiology & Respiratory
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
No device trials list this company as lead sponsor.
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Precision Sampling Set, REF: C20206 for use with the CoSense End-Tidal Carbon Monoxide MonitorOpen, Classified
Z-2198-2025 · Started Apr 21, 2025 · Posted by FDA Jul 29, 2025
Reason given: Sampling set nasal cannula used with End-Tidal Carbon Monoxide (ETCO) monitor may have residual carbon monoxide and volatile organic compounds present due to insufficient aeration of the cannula's carbon filter prior to sealing, which may lead to higher than expected ETOCc scores during clinical evaluations.
Cause as FDA categorized it: Device Design · Device type: Analyzer, Gas, Carbon-Monoxide, Gaseous-Phase (CCJ)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.